Recombinant Mouse IL-2 Protein 212-12-20UG from Thermo Fisher Scientific

Product Specs
ItemRecombinant Mouse IL-2 Protein
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number212-12-20UG
Storage-20°C
Formatno preservative
ApplicationsELISA, Functional Assay, Western Blot
Size20 µg
Molecule NameMouse IL-2
TypeRecombinant
SpeciesMouse
NCBI Full Gene Nameinterleukin 2
NCBI Gene AliasesIl-2

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Dynamic changes of the immune microenvironment in ovarian cancer following neoadjuvant chemotherapyCell Death DiscoveryMarch 23, 2026Mingjie Wu, Fei Lv, Yi Jin, Shuai Wang, Lijun Meng, Jinyi Tong, Ruoyao Zouand seeded in complete medium including ALyS505N-0 medium (#1020P10, Baso, China), 10 ng/mL IL-2 (#212-12-20UG, ThermoFisher, USA), and 10% FBS (#A5669701, Gibco, USA) in a humidified 5% CO2 atmosphere at 37 °C.

(2) Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapySignal Transduction and Targeted TherapySeptember 26, 2025Byeongmin Park, Jiwoong Choi, Jae-Hyeon Lee, Yelee Kim, Woohyeong Lee, Ansoo Lee, In-Cheol Sun, Hong Yeol Yoon, Yongju Kim, Sun Hwa Kim, et al.cells were cultured in RPMI 1640 medium supplemented with recombinant mouse IL-2 (3 U/mL; Cat. No. 212-12-20UG; Gibco) and 2-mercaptoethanol (0.05 mM; Cat. No. 21985023; Thermo Fisher Scientific). After 12 h of

(3) Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinomaCancer CommunicationsMay 29, 2025Jinghan Zhu, Yixiao Xiong, Yuxin Zhang, Huifang Liang, Kun Cheng, Yuanxiang Lu, Guangzhen Cai, Yang Wu, Yunhui Fan, Xiaoping Chen, et al.Sigma‐Aldrich), 1× MEM Amino Acids Solution (#11130051, Gibco), and 20 ng/mL mouse interleukin‐2 (IL‐2) (212‐12‐20UG, Peprotech). Activation of OT‐1 T cells was carried out with Dynabeads Mouse T‐Activator CD3/CD28 (11452D,

(4) Precision Medicine: IL-1RA and Pancreatic Cancer OrganoidsBiology (Basel)May 25, 2025Annah G. Morgan, Michelle F. Griffin, Michael T. Longaker, Jeffrey A. Nortontumor organoids the base medium was supplemented with 500 IU/mL murine recombinant IL-2 protein (Cat# 212-12-20UG; Peprotech, Cranbury, NJ, USA), 50% v/v Wnt-3a conditioned medium (Cat# SCM112; Sigma-Aldrich), 50 ng/mL

(5) STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapyBioactive materialsDecember 1, 2024Nguyen NT, Le XT, Lee WT, Lim YT, Oh KT, Lee ES, Choi HG, Youn YS.USA). Recombinant murine GM-CSF protein (cat. no. 315-03), mouse IL-2 recombinant protein (cat. no. 212-12-20UG) were purchased from PeproTech (Thermo Fisher Scientific, MA, USA). Recombinant mouse IL-4 protein (cat.

(6) A 3D Ex Vivo Tumor-Immune Coculture System Mimicking In Vivo Tumor Environmental Stress on CD8+ T Cells ExhaustionAdv Biol (Weinh)July 1, 2023Meng Z, Niu X, Xia L, Chen Y, Wang Z, Wang H, Ji P, Cui W, Wang Y, Lu S.

(7) Site-Specific Modification of Virus-Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting ImmunitySmall (Weinheim an der Bergstrasse, Germany)June 1, 2023Cheng K, Ma N, Liang J, Ma X, Feng Q, Liu G, Xu C, Tang M, Zhang L, Gao X, et al.

(8) A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyNature biotechnologyApril 1, 2023Quijano-Rubio A, Bhuiyan AM, Yang H, Leung I, Bello E, Ali LR, Zhangxu K, Perkins J, Chun JH, Wang W, et al.

(9) GPR174 knockdown enhances blood flow recovery in hindlimb ischemia mice model by upregulating AREG expressionNature communicationsDecember 6, 2022Liu J, Pan L, Hong W, Chen S, Bai P, Luo W, Sun X, He F, Jia X, Cai J, et al.

(10) Lactate induces metabolic and epigenetic reprogramming of pro-inflammatory Th17 cellsEMBO reportsDecember 6, 2022Lopez Krol A, Nehring HP, Krause FF, Wempe A, Raifer H, Nist A, Stiewe T, Bertrams W, Schmeck B, Luu M, et al.

(11) A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in miceJCI insightNovember 8, 2022Schmitt EG, Toth KA, Risma SI, Kolicheski A, Saucier N, Berríos RJF, Greenberg ZJ, Leiding JW, Bleesing JJ, Thatayatikom A, et al.

(12) Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBMEBioMedicineSeptember 1, 2022Xiong A, Zhang J, Chen Y, Zhang Y, Yang F.

(13) Evaluation of Glutaminolysis in T CellsCurr ProtocSeptember 1, 2022Tajima M, Strober W.

(14) Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast CancerCancer immunology researchJune 3, 2022Gil Del Alcazar CR, Trinh A, Alečković M, Rojas Jimenez E, Harper NW, Oliphant MUJ, Xie S, Krop ED, Lulseged B, Murphy KC, et al.

(15) Natural killer cells act as an extrinsic barrier for in vivo reprogrammingDevelopment (Cambridge, England)April 15, 2022Melendez E, Chondronasiou D, Mosteiro L, Martínez de Villarreal J, Fernández-Alfara M, Lynch CJ, Grimm D, Real FX, Alcamí J, Climent N, et al.

(16) Creatine transport and creatine kinase activity is required for CD8(+) T cell immunityCell reportsMarch 1, 2022Samborska B, Roy DG, Rahbani JF, Hussain MF, Ma EH, Jones RG, Kazak L.

(17) Control of Memory Phenotype T Lymphocyte Homeostasis: Role of CostimulationJournal of immunology (Baltimore, Md. : 1950)February 15, 2022Panda AK, Kim YH, Shevach EM.

(18) Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblastsThe Journal of experimental medicineFebruary 7, 2022Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, Stamoulis P, Goudevenou K, Prados A, Tzaferis C, et al.

(19) Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytesThe Journal of experimental medicineJanuary 3, 2022Evrard M, Wynne-Jones E, Peng C, Kato Y, Christo SN, Fonseca R, Park SL, Burn TN, Osman M, Devi S, et al.

(20) CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapyOncoimmunologyJanuary 1, 2022Li X, Lu M, Yuan M, Ye J, Zhang W, Xu L, Wu X, Hui B, Yang Y, Wei B, et al.

Be the First to Write a Review!

FN

Recombinant Mouse IL-2 Protein from Thermo Fisher Scientific

Thermo Fisher Scientific

Citations (545)

Reviews

Recombinant Mouse IL-2 Protein from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map